Generics News

Generics News

FDA Approves First Generic Nexium

The Food and Drug Administration (FDA) has approved Ivax Pharmaceutical's Esomeprazole Magnesium Delayed-Release Capsules, the first generic version of AstraZeneca's Nexium.

Impax Approved for Generic Lamictal ODT

Impax announced that the Food and Drug Administration (FDA) has approved Lamotrigine Orally Disintegrating Tablets, the generic version of GlaxoSmithKline's Lamictal ODT.

New Phenylephrine HCl Eye Drops Require No Refrigeration

Akorn announced it has received approval from the Food and Drug Administration (FDA) on its New Drug Application (NDA) for Phenylephrine HCl Ophthalmic Solution.

Colchicine 0.6mg Capsules Available from West-Ward

West-Ward, the U.S. division of Hikma Pharmaceuticals, announced the availability of Mitigare (colchicine) capsules and its authorized generic for the prophylaxis of gout flares in adults.

Fresenius Kabi OK'd for Neostigmine Methylsulfate Inj

Fresenius Kabi announced it has received approval from the Food and Drug Administration (FDA) to market Neostigmine Methylsulfate Injection, the generic version of Eclat's Bloxiverz.

Mylan Launches Generic Epivir-HBV

Mylan announced the launch of Lamivudine Tablets, the generic version of GlaxoSmithKline's Epivir-HBV.

Colchicine Tablets Will Soon Be Available Again

Prasco announced that it has partnered with Takeda to launch the authorized generic version of Takeda's Colcrys (colchicine).

Perrigo Launches Generic Clobex Spray

Perrigo announced the launch of Clobetasol Propionate Spray 0.05% , the generic version of Galderma's Clobex Spray.

Perrigo Launches Generic Androgel 1%

Perrigo announced the launch of Testosterone 1% Gel, the generic version of AbbVie's Androgel 1.0%.

Teva Launches Generic Diovan

Teva announced the launch of Valsartan Tablets, the generic version of Novartis' Diovan.